{"Ticker": "MRNA", "Company": "Moderna", "Sector": "Health Care", "Updated": "2022-12-14", "Rating": [{"Date": "2022-12-14", "Rating": "Downgrade", "Organization": "Chardan Capital Markets", "Rating_Change": "Buy to Neutral", "Target_Change": "$186 to $191"}, {"Date": "2022-10-21", "Rating": "Upgrade", "Organization": "SVB Leerink", "Rating_Change": "Underperform to Mkt Perform", "Target_Change": "$174 to $101"}, {"Date": "2022-09-08", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$165"}, {"Date": "2022-02-01", "Rating": "Upgrade", "Organization": "Redburn", "Rating_Change": "Sell to Neutral", "Target_Change": ""}, {"Date": "2022-01-26", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Sell to Hold", "Target_Change": "$175"}, {"Date": "2022-01-21", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$135 to $180"}, {"Date": "2022-01-21", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$221"}, {"Date": "2021-12-07", "Rating": "Initiated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": ""}, {"Date": "2021-11-09", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$304"}, {"Date": "2021-10-22", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Sell", "Target_Change": "$250"}, {"Date": "2021-10-15", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$445"}, {"Date": "2021-08-06", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$246 to $445"}, {"Date": "2021-08-06", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2021-07-15", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$170 to $250"}, {"Date": "2021-02-01", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": ""}, {"Date": "2020-12-16", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$150"}, {"Date": "2020-12-16", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$90 to $150"}, {"Date": "2020-12-09", "Rating": "Downgrade", "Organization": "Needham", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2020-11-23", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$92"}, {"Date": "2020-11-17", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$109"}, {"Date": "2020-09-08", "Rating": "Downgrade", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform to Underperform", "Target_Change": "$58 to $41"}, {"Date": "2020-07-23", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform", "Target_Change": ""}, {"Date": "2020-07-20", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$89"}, {"Date": "2020-07-13", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$90"}, {"Date": "2020-06-30", "Rating": "Initiated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$80"}, {"Date": "2020-06-08", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$68"}, {"Date": "2020-04-30", "Rating": "Initiated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$83"}]}